Literature DB >> 29434491

Usefulness of a Novel Ultrasonographic Classification Based on Anechoic Area Patterns for Differentiating Warthin Tumors from Pleomorphic Adenomas of the Parotid Gland.

Eriko Matsuda1, Takahiro Fukuhara1, Ryohei Donishi1, Katsuyuki Kawamoto1, Yasuaki Hirooka2, Hiromi Takeuchi1.   

Abstract

Background: Ultrasonographic homogeneity is an important differential finding between Warthin tumor and pleomorphic adenoma, two types of benign parotid gland tumors, with the former likely to be heterogeneous and the latter homogeneous. However, differences in the performance of ultrasound machines or the homogeneity cut-off level affect the judgment of ultrasonographic homogeneity. Therefore, in this study, we adopted a novel system for classifying the composition of tumors via ultrasonography, using anechoic area as a substitute for differences in homogeneity to differentiate between Warthin tumors and pleomorphic adenomas.
Methods: We evaluated 68 tumors that were histopathologically diagnosed as Warthin tumor or pleomorphic adenoma between July 2009 and November 2015. Ultrasonographic images of the tumors were evaluated on the basis of key differentiating features, including features on B-mode imaging and color Doppler imaging. Additionally, the tumors were classified into four groups based on anechoic area, and findings were compared between Warthin tumors and pleomorphic adenomas.
Results: While 38 of the tumors were pleomorphic adenomas, 30 were Warthin tumors. The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy for detection of Warthin tumors using our novel classification system were 73.3%, 76.3%, 71.0%, 78.4% and 75.0%, respectively. Compared to pleomorphic adenomas, Warthin tumors showed large or sponge-like anechoic areas, rich vascularization and an oval shape even at large tumor sizes, and the difference was significant. On defining Warthin tumor as a tumor demonstrating two or more of the findings noted above, the sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy for its detection were 73.3%, 84.2%, 78.6%, 80.0% and 79.4%, respectively.
Conclusion: Our novel classification system based on anechoic area patterns demonstrated by the tumors had high sensitivity, specificity and diagnostic accuracy for differentiating Warthin tumors from pleomorphic adenomas.

Entities:  

Keywords:  Warthin tumor; diagnostic imaging; parotid neoplasms; pleomorphic adenoma; ultrasonography

Year:  2018        PMID: 29434491      PMCID: PMC5803158          DOI: 10.24563/yam.2017.12.002

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  16 in total

1.  Pleomorphic adenoma and adenolymphoma in ultrasonography.

Authors:  P Zajkowski; W Jakubowski; E J Białek; M Wysocki; A Osmólski; M Serafin-Król
Journal:  Eur J Ultrasound       Date:  2000-09

2.  Multimodal ultrasonographic characterisation of parotid gland lesions--a pilot study.

Authors:  Andreas Knopf; Naglaa Mansour; Adam Chaker; Murat Bas; Konrad Stock
Journal:  Eur J Radiol       Date:  2012-01-24       Impact factor: 3.528

3.  An analysis of the treatment of 114 patients with recurrent pleomorphic adenomas of the parotid gland.

Authors:  A Renehan; E N Gleave; M McGurk
Journal:  Am J Surg       Date:  1996-12       Impact factor: 2.565

4.  Statistical study for sonographic differential diagnosis of tumorous lesions in the parotid gland.

Authors:  M Shimizu; J Ussmüller; J Hartwein; K Donath; N Kinukawa
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1999-08

5.  Differentiation of pleomorphic adenoma and Warthin's tumor of the parotid gland: ultrasonographic features.

Authors:  Xueyu Rong; Qiang Zhu; Hongtao Ji; Jiangping Li; Huilian Huang
Journal:  Acta Radiol       Date:  2013-12-09       Impact factor: 1.990

Review 6.  Major and minor salivary gland tumors.

Authors:  Marco Guzzo; Laura D Locati; Franz J Prott; Gemma Gatta; Mark McGurk; Lisa Licitra
Journal:  Crit Rev Oncol Hematol       Date:  2009-11-24       Impact factor: 6.312

7.  Color Doppler sonography of salivary glands.

Authors:  C Martinoli; L E Derchi; L Solbiati; G Rizzatto; E Silvestri; M Giannoni
Journal:  AJR Am J Roentgenol       Date:  1994-10       Impact factor: 3.959

8.  Characteristic sonographic findings of Warthin's tumor in the parotid gland.

Authors:  Jinna Kim; Eun-Kyung Kim; Cheong Soo Park; Yoon-Seok Choi; Young Ho Kim; Eun Chang Choi
Journal:  J Clin Ultrasound       Date:  2004-02       Impact factor: 0.910

9.  Incidence of salivary gland neoplasms in a defined UK population.

Authors:  Patrick J Bradley; Mark McGurk
Journal:  Br J Oral Maxillofac Surg       Date:  2012-10-24       Impact factor: 1.651

10.  Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.

Authors:  Hidetake Yabuuchi; Tatsuro Fukuya; Tsuyoshi Tajima; Yoichi Hachitanda; Kichinobu Tomita; Mitsuru Koga
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

View more
  3 in total

1.  The effectiveness of high-resolution ultrasound in the assessment of the carotid intima-media thickness for postirradiated neck.

Authors:  Yu-Chun Yeh; Kai-Min Fang; Wan-Lun Hsu; Li-Jen Liao
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-25       Impact factor: 2.503

2.  Diagnostic performance of qualitative and radiomics approach to parotid gland tumors: which is the added benefit of texture analysis?

Authors:  Federica Vernuccio; Federica Arnone; Roberto Cannella; Barbara Verro; Albert Comelli; Francesco Agnello; Alessandro Stefano; Rosalia Gargano; Vito Rodolico; Giuseppe Salvaggio; Roberto Lagalla; Massimo Midiri; Antonio Lo Casto
Journal:  Br J Radiol       Date:  2021-09-30       Impact factor: 3.039

3.  Impact of Screening for Salivary Gland by Ultrasonography.

Authors:  Kanna Onda; Takahiro Fukuhara; Eriko Matsuda; Ryohei Donishi; Yasuaki Hirooka; Hiromi Takeuchi; Masahiko Kato
Journal:  Yonago Acta Med       Date:  2020-01-30       Impact factor: 1.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.